Xingjuan (Jane) Chao
Also at Ceribell
About
Xingjuan (Jane) Chao, aged 45 as of April 11, 2025 , combines a strong scientific academic background with extensive leadership experience. She earned a B.S. in chemistry from Peking University and a Ph.D. in biophysics from Cornell University, establishing the foundation for a career that spans both research and executive management.
Before joining CBLL, she garnered significant experience through roles at prominent organizations, including serving as a management consultant at McKinsey & Company (July 2007–January 2013), as Senior Strategy Manager at Novartis AG (January 2013–June 2014), and as Principal Manager of Portfolio Management Strategy at Genentech, Inc. (June 2014–August 2015).
Since joining CBLL as Chief Executive Officer in October 2015 and later being promoted to President in July 2016, her leadership has been pivotal in steering the company’s strategic direction. Her contributions extend to board memberships and key industry agreements, underscoring a well-rounded professional profile that supports both operational and strategic growth.